Quarter Period Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7302244

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Quarter period consolidated statement of income
Statement of income
Net sales
56,000 JPY
44,000 JPY
Cost of sales
14,000 JPY
11,000 JPY
Gross profit (loss)
42,000 JPY
33,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
542,601,000 JPY
550,603,000 JPY
Operating profit (loss)
-542,559,000 JPY
-550,569,000 JPY
Non-operating income
Interest income
47,000 JPY
6,000 JPY
Non-operating income
8,089,000 JPY
193,000 JPY
Non-operating expenses
Non-operating expenses
3,316,000 JPY
1,190,000 JPY
Ordinary profit (loss)
-537,786,000 JPY
-551,566,000 JPY
Extraordinary losses
Impairment losses
JPY
1,406,000 JPY
Extraordinary losses
JPY
1,406,000 JPY
Profit (loss) before income taxes
-537,786,000 JPY
-552,972,000 JPY
Income taxes - current
950,000 JPY
950,000 JPY
Income taxes
950,000 JPY
950,000 JPY
Profit (loss)
-538,736,000 JPY
-553,922,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.